With Momentum

Biofourmis

The AI engine Fit Assessment

Beta

Biofourmis excels in remote patient monitoring, advancing clinical trials, and identifying digital biomarkers, making it a strong fit for the specified requirements.

Blurb

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

HQ Location

Boston (United States)

Founded

2015

Employees

201 - 500

Total funding raised

$463.57M

Funding Status

Acquired by CopilotIQ, October 2024
Subspaces
  • Digital Biomarkers Development

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes.



Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science smarter, healthcare simpler, and patients healthier.



Biofourmis is a global technology company enabling care delivery, with headquarters in Boston with key offices in Singapore and India. For more information, visit biofourmis.com and follow Biofourmis on LinkedIn, Twitter and YouTube.